Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Mar 10;87(3):301-307.
doi: 10.1292/jvms.24-0231. Epub 2025 Feb 4.

Upregulation of lipocalin-2 in the retina of experimental autoimmune uveitis

Affiliations

Upregulation of lipocalin-2 in the retina of experimental autoimmune uveitis

Hyeonju Kim et al. J Vet Med Sci. .

Abstract

Lipocalin-2, a siderophore-binding protein, is an antimicrobial, exerting both pro-inflammatory and anti-inflammatory actions. Lipocalin-2 is also involved in glial activation, matrix metalloproteinase stabilization, and cellular iron flux, all of which play roles in autoimmune diseases. The present study aimed to determine the expression of lipocalin-2 in the eyes of Lewis rats with interphotoreceptor-binding protein-induced experimental autoimmune uveitis (EAU). Significantly elevated serum lipocalin-2 levels were also detected in rats by enzyme-linked immunosorbent assay (ELISA). Lipocalin-2 immunostaining was detected predominantly in activated glial cells, including glutamine synthase-positive Müller cells, and ionized calcium-binding adaptor molecule 1-positive microglia and macrophages in EAU rats. Taken together, the results presented herein show that lipocalin-2 is a potential diagnostic marker for uveitis.

Keywords: ciliary body; experimental autoimmune uveitis; lipocalin-2; retina.

PubMed Disclaimer

Conflict of interest statement

The authors confirm that there is no conflict of interest.

Figures

Fig. 1.
Fig. 1.
Serum lipocalin-2 levels in normal control and IRBP-immunized rats. The levels of lipocalin-2 in EAU rats on days 9 and 14 post-immunization were significantly higher than those in normal controls and declined by day 21. Values are shown as means ± SEM (n=4 for each group). **P<0.01. EAU: experimental autoimmune uveitis; D9PI, day 9 post-immunization; D14PI, day 14 post-immunization; D21PI, day 21 post-immunization; EAU, experimental autoimmune uveitis; IRBP, interphotoreceptor retinoid-binding protein; SEM, standard error of the mean.
Fig. 2.
Fig. 2.
Histopathological findings of the uvea and retina of normal (A and C) and IRBP-immunized rats (B and D). No inflammation was observed in the uvea (C) or retina of normal rats (A). On day 9 post-immunization, infiltration of inflammatory cells was observed in the ciliary body (D) and retina of EAU rats (B). The arrows indicate infiltrating inflammatory cells. Scale bars in A–D: 20 µm. D9PI, day 9 post-immunization; EAU, experimental autoimmune uveitis; GCL, ganglion cell layer; INL, inner nuclear layer; IPL, inner plexiform layer; IRBP, interphotoreceptor retinoid-binding protein; IS/OS, inner segment/outer segment junction; ONL, outer nuclear layer; RPE, retinal pigment epithelium.
Fig. 3.
Fig. 3.
Immunohistochemical localization of lipocalin-2 in the eyes of normal (A and C) and EAU-induced rats on days 9 (B and D). Lipocalin-2 immunostaining is observed in the GCL and RPE of the eyes (A) and in the ciliary body of normal rats (C). Lipocalin-2-positive immunoreaction was also enhanced in the GCL, IPL, and ONL of the retina (B). Lipocalin-2 was also detected in inflammatory cells in the ciliary region of EAU rats on day 9 post-immunization (D). The arrows denote inflammatory cells. Scale bars in A–D: 20 µm. D9PI, day 9 post-immunization; EAU, experimental autoimmune uveitis; GCL, ganglion cell layer; INL, inner nuclear layer; IPL, inner plexiform layer; IRBP, interphotoreceptor retinoid-binding protein; IS/OS, inner segment/outer segment junction; ONL, outer nuclear layer; RPE, retinal pigment epithelium.
Fig. 4.
Fig. 4.
Double-labeling immunofluorescence analysis of lipocalin-2 and GS in the retina of EAU rats. Double-labeling immunofluorescence for lipocalin-2 (A) and the Müller cell marker GS in the retina of EAU rats on day 9 post-immunization (B). Lipocalin-2 is localized in GS-positive Müller cells (C). Arrowheads, Müller cells with lipocalin-2-positive and GS-positive immunoreactions. Scale bars in A–C: 20 µm. EAU, experimental autoimmune uveitis; GS, glutamine synthase.
Fig. 5.
Fig. 5.
Double-labeling immunofluorescence analysis of lipocalin-2 and Iba1 in the retina and ciliary body of EAU-induced rats. Double-labeling immunofluorescence of lipocalin-2 and the microglial marker Iba1 in the retina of EAU rats on day 9 post-immunization. Lipocalin-2 (green: A and D) was occasionally localized in some Iba1-positive microglia in the retina (red: B) and in macrophages (red: E) in the ciliary bodies of EAU-induced rats (yellow: C and F). Arrowheads, microglia, and/or macrophages showing lipocalin-2-positive and Iba1-positive immunoreactions. Scale bars in A–F: 20 µm. EAU, experimental autoimmune uveitis; Iba1, ionized calcium-binding adaptor molecule 1.

Similar articles

References

    1. Abcouwer SF, Lin CM, Shanmugam S, Muthusamy A, Barber AJ, Antonetti DA. 2013. Minocycline prevents retinal inflammation and vascular permeability following ischemia-reperfusion injury. J Neuroinflammation 10: 149. doi: 10.1186/1742-2094-10-149 - DOI - PMC - PubMed
    1. Agarwal RK, Silver PB, Caspi RR. 2012. Rodent models of experimental autoimmune uveitis. Methods Mol Biol 900: 443–469. doi: 10.1007/978-1-60761-720-4_22 - DOI - PMC - PubMed
    1. Basu S, Hassman L, Kodati S, Chu CJ. 2024. Intraocular immune response in human uveitis: time to look beyond animal models. Am J Ophthalmol 266: 17–25. doi: 10.1016/j.ajo.2024.04.026 - DOI - PMC - PubMed
    1. Behrens V, Voelz C, Müller N, Zhao W, Gasterich N, Clarner T, Beyer C, Zendedel A. 2021. Lipocalin 2 as a putative modulator of local inflammatory processes in the spinal cord and component of organ cross talk after spinal cord injury. Mol Neurobiol 58: 5907–5919. doi: 10.1007/s12035-021-02530-7 - DOI - PubMed
    1. Berard JL, Zarruk JG, Arbour N, Prat A, Yong VW, Jacques FH, Akira S, David S. 2012. Lipocalin 2 is a novel immune mediator of experimental autoimmune encephalomyelitis pathogenesis and is modulated in multiple sclerosis. Glia 60: 1145–1159. doi: 10.1002/glia.22342 - DOI - PubMed